Study Status
Re-verified, no change to tracked fields
v29
Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00005152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialStudy Status
Re-verified, no change to tracked fields
v29
Primary and study completion dates: Mar 31, 2024 to Jun 1, 2029
Study description expanded, about 15 words
Study Status, Study Descriptionv28
3 amendments
3 re-verifications since 2022-03-01, no change to tracked fields
v25-v27
Primary and study completion dates: Mar 31, 2022 to Mar 31, 2024
Study Identification, Study Statusv24
3 amendments
3 re-verifications since 2019-12-09, no change to tracked fields
v21-v23
Primary and study completion dates: May 2019 to Mar 31, 2022
Study description expanded, about 23 words
Study Status, Study Description, Outcome Measures, Referencesv20
Study Status
Re-verified, no change to tracked fields
v19
Primary and study completion dates: Mar 2018 to May 2019
Primary endpoint revised; Study description revised
Study Status, Study Description, Outcome Measuresv18
Primary and study completion dates: Aug 2008 to Mar 2018
Trial status: Completed to Active, Not Recruiting; Eligibility criteria revised; Study description expanded, about 132 words; and 1 more
Study Identification, Study Status, Study Description, Eligibility, Referencesv17
7 amendments
7 re-verifications since 2014-04-04, no change to tracked fields
v10-v16
Publications: 89 to 124
Study Status, Referencesv9
Enrollment target: 121700
Study Status, Study Design, Outcome Measuresv8
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to Brigham and Women's Hospital
Collaborators expanded, about 7 words; Study title expanded, about 2 words
Study Identification, Study Status, Sponsor/Collaborators, Oversight, Study Design, Eligibility, Contacts/Locations, Referencesv7
Trial status: Active, Not Recruiting to Completed
Primary completion date: Aug 2008; Completion date: Aug 2007 to Aug 2008
Study Status, Study Design, Eligibilityv6
Publications: 88 to 89
Study Status, Referencesv5
Publications: 86 to 88
Study Status, Referencesv4
Publications: 85 to 86
Study Status, Referencesv3
Publications: 84 to 85
Study Status, Referencesv2
Study First Submitted
| NCT Number | NCT00005152 |
| Lead Sponsor | Brigham and Women's Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI) |
| Conditions | Cardiovascular Diseases, Diabetes Mellitus, Coronary Disease, Heart Diseases, Cerebrovascular Accident, Pulmonary Embolism, Angina Pectoris, Myocardial Infarction +2 more |
| Enrollment | 121,700 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |